Sam Slutsky
Stock Analyst at LifeSci Capital
(1.38)
# 3,505
Out of 4,964 analysts
3
Total ratings
66.67%
Success rate
-4.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sam Slutsky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PVLA Palvella Therapeutics | Initiates: Outperform | $90 | $51.75 | +73.91% | 1 | Aug 4, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Outperform | $45 → $101 | $81.64 | +23.71% | 1 | Jul 23, 2025 | |
| IFRX InflaRx | Upgrades: Outperform | n/a | $1.17 | - | 1 | Apr 5, 2023 |
Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $51.75
Upside: +73.91%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45 → $101
Current: $81.64
Upside: +23.71%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $1.17
Upside: -